W

Lilly raises outlook for third time this year as Zepbound sales soar

商业管理
分享到
Lilly raises outlook for third time this year as Zepbound sales soar

The GLP-1 drug continues to dominate the market for prescription weight-loss drugs in the U.S.

Lilly raises outlook for third time this year as Zepbound sales soar

Source：MarketWatch

友情提醒：請廣大讀者理性看待市場資訊，切實提高風險意識。站內所有內容僅系市場資訊或相關方觀點，不構成任何形式投資建議。

延伸閱讀

Deutsche Bank launches crypto custody for companies and institutions

Clients can store and transfer Bitcoin, Ether and select stablecoins through the bank, which manages their wallets and private keys. Source：Cointelegraph

Micron and other AI stocks surge as CoreWeave calms Wall Street’s worst fears

CoreWeave’s improved AI economics and its vow to show some discipline around future debt are sparking a broad rally across the chip sector. Source：MarketWatch

Paraguay bank collapse shows stablecoins can offer a lifeline... of sorts

Ueno’s collapse exposed the fragility of digital banking in Paraguay, as customers scrambled for access to their money and stablecoins offered a lifeline.…

Bitcoin Covenants Part 5: MATT and OP_CHECKCONTRACTVERIFY — How Bitcoin could carry state across transactions

OPCCV embeds contract state directly into Taproot output keys and enforces valid state transitions onchain. This makes it possible to achieve stateful…

來源：https://www.marketwatch.com/story/lilly-raises-outlook-for-third-time-this-year-as-zepbound-sales-soar-6d987407